Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kay

Showing results (701-710 of 861) with videos related to

Pageof 87
Sort By:
Science (New York, N.Y.)|June 11, 1998
Closing the circadian loop: CLOCK-induced transcription of its own inhibitors per and timT K Darlington, K Wager-Smith, M F Ceriani, et al.
Cell|September 6, 2001
A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genesJ B Hogenesch, K A Ching, S Batalov, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
Nature|January 7, 2014
Selection and evaluation of clinically relevant AAV variants in a xenograft liver modelLeszek Lisowski, Allison P Dane, Kirk Chu, et al.
Nature|November 4, 2014
Control of plant stem cell function by conserved interacting transcriptional regulatorsYun Zhou, Xing Liu, Eric M Engstrom, et al.
JCI Insight|June 19, 2019
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseasesAlessia De Caneva, Fabiola Porro, Giulia Bortolussi, et al.
Plos One|June 23, 2011
Global profiling of rice and poplar transcriptomes highlights key conserved circadian-controlled pathways and cis-regulatory modulesSergei A Filichkin, Ghislain Breton, Henry D Priest, et al.
Human Gene Therapy|April 14, 2016
A Tribute to George StamatoyannopoulosArun Srivastava, Mark A Kay, Takis Athanasopoulos, et al.
Frontiers in Genome Editing|April 1, 2022
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal MiceMichela Lisjak, Alessia De Caneva, Thibaut Marais, et al.
Nature Medicine|March 4, 2000
Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta virusesK Ohashi, P L Marion, H Nakai, et al.
Pageof 87

Showing results (701-710 of 861) with videos related to

Sort By:
Pageof 87
Science (New York, N.Y.)|June 11, 1998
Closing the circadian loop: CLOCK-induced transcription of its own inhibitors per and timT K Darlington, K Wager-Smith, M F Ceriani, et al.
Cell|September 6, 2001
A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genesJ B Hogenesch, K A Ching, S Batalov, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
Nature|January 7, 2014
Selection and evaluation of clinically relevant AAV variants in a xenograft liver modelLeszek Lisowski, Allison P Dane, Kirk Chu, et al.
Nature|November 4, 2014
Control of plant stem cell function by conserved interacting transcriptional regulatorsYun Zhou, Xing Liu, Eric M Engstrom, et al.
JCI Insight|June 19, 2019
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseasesAlessia De Caneva, Fabiola Porro, Giulia Bortolussi, et al.
Plos One|June 23, 2011
Global profiling of rice and poplar transcriptomes highlights key conserved circadian-controlled pathways and cis-regulatory modulesSergei A Filichkin, Ghislain Breton, Henry D Priest, et al.
Human Gene Therapy|April 14, 2016
A Tribute to George StamatoyannopoulosArun Srivastava, Mark A Kay, Takis Athanasopoulos, et al.
Frontiers in Genome Editing|April 1, 2022
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal MiceMichela Lisjak, Alessia De Caneva, Thibaut Marais, et al.
Nature Medicine|March 4, 2000
Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta virusesK Ohashi, P L Marion, H Nakai, et al.
Pageof 87